
Overview
A&A Biotechnology is a Polish biotechnology company founded in 1993 by Dr. Adam Burkiewicz that develops and manufactures products for the life sciences sector. It operates its own research laboratories and production facilities, with products including Gut Microbiome, MagnifiQ™ Pathogen, BacBreaker, and mutanolysin for research and diagnostics.
Financials
Revenue history
From the notes
| Current income tax (CIT due) | $0 |
Filing timeliness
2 of 4 financial statements were filed late (the longest delay 550 days for 2022).
- 202508/07/2026
- 202415/05/2025
- 202315/05/2025
- 202215/01/2025
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Public procurement
1 tender recorded as contractor, with a total value of $3,388.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Jul 2, 2026 | Purchase and delivery of reagents and consumables for tests covered by the NPZ project – 15 tasks | $3,388$3,388 | Instytut Medycyny Wsi Im. Witolda Chodźki |
A&A Biotechnology is the contractor in 27 public sector contracts, worth USD 21.37k in total. They were signed with 8 public buyers. The largest number (2) were signed with Centrum Onkologii Im. Prof. Franciszka Łukaszczyka w Bydgoszczy.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Oct 22, 2026 | Reagents | $461.19 | Uniwersytet Medyczny w Łodzi | |
| Oct 7, 2026 | Reagents | $981.90 | Uniwersytet Medyczny w Łodzi | |
| Oct 5, 2026 | Reagents | $128.58 | Uniwersytet Medyczny w Łodzi |
Authorized Representatives
Manner of representation
In the case of a multi-member management board, the President of the Management Board and the Vice-President are authorised to make declarations of will, incur liabilities and sign on behalf of the company independently, while the remaining members of the management board are authorised to do so jointly within two-person representation.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Adam Mikołaj Burkiewiczage 72 | 1,000 | $13,506.21 | 50% |
Ewelina Elżbieta Dajnowska Burkiewiczage 72 | 1,000 | $13,506.21 | 50% |
Adam Mikołaj Burkiewicz and Ewelina Elżbieta Dajnowska Burkiewicz hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2022-07-01.
09 1020 4900 0000 8202 3446 1616
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Oceanicsp. z o.o. | $82,901,772.15 | oceanic.com.pl | ||
| BIO-Lidersp. k. | $24,998,818.05 | bio-lider.pl | ||
| Bio-Gensp. z o.o. | $17,565,830.56 | bio-gen.pl | ||
| BiomaximaS.A. | $14,936,464.09 | biomaxima.com | ||
| Andermatt Polskasp. z o.o. | $1,241,417.72 | andermatt.pl | ||
| Biobaktsp. z o.o. | $1,134,364.12 | biobakt.pl | ||
| Poli-Farmsp. z o.o. | $694,656.88 | poli-farm.pl | ||
| Agricis Smart Sciencesp. z o.o. | $446,324.81 | agricis.com | ||
| Futuresynthesissp. z o.o. | $282,270.22 | futuresynthesis.pl | ||
| Babybiomsp. z o.o. | $30,166.99 | babybiom.pl |
FAQ
Last updated: 2026-07-15